Therapeutic drug monitoring following crushed administration of delayed-release posaconazole tablets via enteral feeding tubes

被引：9
|
作者：
Stevens, Ryan W. [1 ]
O'Connell, Casey [1 ]
Huang, Angie [2 ]
Epps, Kevin L. [3 ]
Ilges, Dan [2 ]
机构：
[1] Mayo Clin, Dept Pharm Serv, 200 1st St SW, Rochester, MN 55902 USA
[2] Mayo Clin, Dept Pharm Serv, Scottsdale, AZ USA
[3] Mayo Clin, Dept Pharm Serv, Jacksonville, FL USA
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2023年 / 78卷 / 02期
关键词：
ASPERGILLOSIS;
D O I：
10.1093/jac/dkac427
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页码：553 / 555
页数：3
相关论文
共 25 条
  • [1] Crushed Posaconazole Delayed-Release Tablets Via Enteral Feeding Tubes: A Cautionary Tale
    Kane, Nicholas
    Rikard, Rachel
    McCrory, Katie
    Marx, Ashley
    [J]. ANNALS OF PHARMACOTHERAPY, 2024,
  • [2] Reply: Crushed Posaconazole Delayed-Release Tablets Via Enteral Feeding Tubes: A Cautionary Tale
    Kane, Nicholas
    Marx, Ashley
    [J]. ANNALS OF PHARMACOTHERAPY, 2024,
  • [3] Successful enteral administration of crushed posaconazole delayed-release tablets in children
    Bio, Laura L.
    Hiroshima, Lyndsie
    Schwenk, Hayden T.
    Green, Sean
    [J]. PEDIATRIC BLOOD & CANCER, 2024, 71 (02)
  • [4] Enteral feeding tube administration with therapeutic drug monitoring of crushed posaconazole tablets and opened isavuconazonium sulfate capsules
    Dieringer, Thomas D.
    Schaenman, Joanna M.
    Davis, Matthew R.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (05) : 1417 - 1423
  • [5] Serum Levels of Crushed Posaconazole Delayed-Release Tablets
    Mason, Mathew J.
    McDaneld, Patrick M.
    Musick, William L.
    Kontoyiannis, Dimitrios P.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (05)
  • [6] Therapeutic Drug Monitoring of Crushed Posaconazole Delayed Release Tablets in Lung Transplant Patients.
    Sial, S.
    Cunningham, K.
    Moore, J.
    Dagostino, C.
    Lang, K.
    Kane, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 987 - 988
  • [7] Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis
    Kosmidis, Chris
    Rodriguez-Goncer, Isabel
    Rautemaa-Richardson, Riina
    Richardson, Malcolm D.
    Moore, Caroline B.
    Denning, David W.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (04) : 1056 - 1061
  • [8] Efficacy of Crushed Delayed-Release Posaconazole Tablets in Rhino-Orbito-Cerebral Mucormycosis
    Manesh, Abi
    Devasagayam, Emily
    Bhanuprasad, Kundakarla
    Mathew, Sumith K.
    Karthik, Rajiv
    Mathew, Binu S.
    Varghese, George M.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (12)
  • [9] Administering Crushed Posaconazole Delayed-Release Tablets Should not be Assumed to Behave Pharmacokinetically as if Swallowed Intact
    Stevens, Ryan W.
    Wieruszewski, Patrick M.
    Ilges, Dan
    [J]. ANNALS OF PHARMACOTHERAPY, 2024,
  • [10] Drug administration via enteral feeding tubes
    Lorent, S.
    Lievin, V.
    Ballarin, A.
    Van Gossum, A.
    Preiser, J. -C.
    [J]. REANIMATION, 2011, 20 (04): : 354 - 357
123